A citation-based method for searching scientific literature

Chee W Chia, Josephine M Egan. Ann N Y Acad Sci 2020
Times Cited: 34







List of co-cited articles
220 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glucagon-like peptide 1 (GLP-1).
T D Müller, B Finan, S R Bloom, D D'Alessio, D J Drucker, P R Flatt, A Fritsche, F Gribble, H J Grill, J F Habener,[...]. Mol Metab 2019
472
26


Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
17

Incretin hormones: Their role in health and disease.
Michael A Nauck, Juris J Meier. Diabetes Obes Metab 2018
272
14

Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.
S Calanna, M Christensen, J J Holst, B Laferrère, L L Gluud, T Vilsbøll, F K Knop. Diabetologia 2013
157
14


Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Marc A Pfeffer, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars V Køber, Francesca C Lawson, Lin Ping, Xiaodan Wei, Eldrin F Lewis,[...]. N Engl J Med 2015
11

GLP-1: Molecular mechanisms and outcomes of a complex signaling system.
Nicholas K Smith, Troy A Hackett, Aurelio Galli, Charles R Flynn. Neurochem Int 2019
35
11

Pharmacology, physiology, and mechanisms of incretin hormone action.
Jonathan E Campbell, Daniel J Drucker. Cell Metab 2013
858
11


Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2.
Gwen Tolhurst, Helen Heffron, Yu Shan Lam, Helen E Parker, Abdella M Habib, Eleftheria Diakogiannaki, Jennifer Cameron, Johannes Grosse, Frank Reimann, Fiona M Gribble. Diabetes 2012
8

Targeting adipose tissue in the treatment of obesity-associated diabetes.
Christine M Kusminski, Perry E Bickel, Philipp E Scherer. Nat Rev Drug Discov 2016
389
8

Three Pillars for the Neural Control of Appetite.
Scott M Sternson, Anne-Kathrin Eiselt. Annu Rev Physiol 2017
130
8

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Adrian F Hernandez, Jennifer B Green, Salim Janmohamed, Ralph B D'Agostino, Christopher B Granger, Nigel P Jones, Lawrence A Leiter, Anne E Rosenberg, Kristina N Sigmon, Matthew C Somerville,[...]. Lancet 2018
839
8


Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
8

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
8

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Mansoor Husain, Andreas L Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G Eliaschewitz, Denise R Franco, Ole K Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D Pedersen,[...]. N Engl J Med 2019
642
8

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Rury R Holman, M Angelyn Bethel, Robert J Mentz, Vivian P Thompson, Yuliya Lokhnygina, John B Buse, Juliana C Chan, Jasmine Choi, Stephanie M Gustavson, Nayyar Iqbal,[...]. N Engl J Med 2017
8

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Hertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, Rafael Diaz, Mark Lakshmanan, Prem Pais, Jeffrey Probstfield, Jeffrey S Riesmeyer, Matthew C Riddle, Lars Rydén,[...]. Lancet 2019
8


Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function.
Jordan Rowlands, Julian Heng, Philip Newsholme, Rodrigo Carlessi. Front Endocrinol (Lausanne) 2018
119
8

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
Anna Secher, Jacob Jelsing, Arian F Baquero, Jacob Hecksher-Sørensen, Michael A Cowley, Louise S Dalbøge, Gitte Hansen, Kevin L Grove, Charles Pyke, Kirsten Raun,[...]. J Clin Invest 2014
452
8

GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.
Daniel Beiroa, Monica Imbernon, Rosalía Gallego, Ana Senra, Daniel Herranz, Francesc Villarroya, Manuel Serrano, Johan Fernø, Javier Salvador, Javier Escalada,[...]. Diabetes 2014
335
8

Stimulation of insulin secretion by gastric inhibitory polypeptide in man.
J Dupre, S A Ross, D Watson, J C Brown. J Clin Endocrinol Metab 1973
739
8

Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies.
Salvatore Calanna, Mikkel Christensen, Jens J Holst, Blandine Laferrère, Lise L Gluud, Tina Vilsbøll, Filip K Knop. Diabetes Care 2013
99
8

Newer GLP-1 receptor agonists and obesity-diabetes.
Emily Brown, Daniel J Cuthbertson, John P Wilding. Peptides 2018
37
8

Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake.
Alice E Adriaenssens, Emma K Biggs, Tamana Darwish, John Tadross, Tanmay Sukthankar, Milind Girish, Joseph Polex-Wolf, Brain Y Lam, Ilona Zvetkova, Warren Pan,[...]. Cell Metab 2019
102
8

Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases.
Andre F Batista, Victor Bodart-Santos, Fernanda G De Felice, Sergio T Ferreira. CNS Drugs 2019
36
8

Glucose-sensing in glucagon-like peptide-1-secreting cells.
Frank Reimann, Fiona M Gribble. Diabetes 2002
214
8

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
Kiwon Ban, M Hossein Noyan-Ashraf, Judith Hoefer, Steffen-Sebastian Bolz, Daniel J Drucker, Mansoor Husain. Circulation 2008
772
8

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.
D J Drucker, J Philippe, S Mojsov, W L Chick, J F Habener. Proc Natl Acad Sci U S A 1987
652
8

Oral Glucose Tolerance Test Glucose Peak Time Is Most Predictive of Prediabetes and Hepatic Steatosis in Obese Girls.
Melanie Cree-Green, Danielle Xie, Haseeb Rahat, Yesenia Garcia-Reyes, Bryan C Bergman, Ann Scherzinger, Cecilia Diniz Behn, Christine L Chan, Megan M Kelsey, Laura Pyle,[...]. J Endocr Soc 2018
18
11

β-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes.
Sara F Michaliszyn, Andrea Mari, SoJung Lee, Fida Bacha, Hala Tfayli, Lama Farchoukh, Ele Ferrannini, Silva Arslanian. Diabetes 2014
57
5


Glucose response curve and type 2 diabetes risk in Latino adolescents.
Joon Young Kim, Dawn K Coletta, Lawrence J Mandarino, Gabriel Q Shaibi. Diabetes Care 2012
49
5

The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes.
Muhammad A Abdul-Ghani, Valeriya Lyssenko, Tiinamaija Tuomi, Ralph A Defronzo, Leif Groop. Diabetes Metab Res Rev 2010
89
5

Assessing the shape of the glucose curve during an oral glucose tolerance test.
Otto Tschritter, Andreas Fritsche, Fatemeh Shirkavand, Fausto Machicao, Hans Häring, Michael Stumvoll. Diabetes Care 2003
109
5


Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: Who is worse off?
Silva Arslanian, Joon Young Kim, Alexis Nasr, Fida Bacha, Hala Tfayli, SoJung Lee, Frederico G S Toledo. Pediatr Diabetes 2018
38
5

The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth.
Joon Young Kim, Sara F Michaliszyn, Alexis Nasr, SoJung Lee, Hala Tfayli, Tamara Hannon, Kara S Hughan, Fida Bacha, Silva Arslanian. Diabetes Care 2016
53
5



Effect of chronic liraglutide therapy and its withdrawal on time to postchallenge peak glucose in type 2 diabetes.
Susan Tran, Caroline K Kramer, Bernard Zinman, Haysook Choi, Ravi Retnakaran. Am J Physiol Endocrinol Metab 2018
9
22




Selective activation of Gs signaling in adipocytes causes striking metabolic improvements in mice.
Lei Wang, Sai P Pydi, Yinghong Cui, Lu Zhu, Jaroslawna Meister, Oksana Gavrilova, Rebecca Berdeaux, Jean-Philippe Fortin, Kendra K Bence, Cecile Vernochet,[...]. Mol Metab 2019
18
11

FoxO1 target Gpr17 activates AgRP neurons to regulate food intake.
Hongxia Ren, Ian J Orozco, Ya Su, Shigetomo Suyama, Roger Gutiérrez-Juárez, Tamas L Horvath, Sharon L Wardlaw, Leona Plum, Ottavio Arancio, Domenico Accili. Cell 2012
133
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.